DrugPatentWatch Database Preview
CALCIUM GLUCONATE IN SODIUM CHLORIDE Drug Profile
» See Plans and Pricing
When do Calcium Gluconate In Sodium Chloride patents expire, and what generic alternatives are available?
Calcium Gluconate In Sodium Chloride is a drug marketed by Hq Spclt Pharma and is included in one NDA. There are two patents protecting this drug.
The generic ingredient in CALCIUM GLUCONATE IN SODIUM CHLORIDE is calcium gluconate. There are two hundred and eighty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the calcium gluconate profile page.
US ANDA Litigation and Generic Entry Outlook for Calcium Gluconate In Sodium Chloride
A generic version of CALCIUM GLUCONATE IN SODIUM CHLORIDE was approved as calcium gluconate by FRESENIUS KABI USA on June 15th, 2017.
Summary for CALCIUM GLUCONATE IN SODIUM CHLORIDE
| US Patents: | 2 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Clinical Trials: | 25 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | CALCIUM GLUCONATE IN SODIUM CHLORIDE at DailyMed |
Recent Clinical Trials for CALCIUM GLUCONATE IN SODIUM CHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Medical Universtity of Lodz | Phase 4 |
| University of Malaya | Phase 4 |
| IRCCS Policlinico S. Matteo | Phase 3 |
See all CALCIUM GLUCONATE IN SODIUM CHLORIDE clinical trials
Pharmacology for CALCIUM GLUCONATE IN SODIUM CHLORIDE
| Drug Class | Blood Coagulation Factor |
| Physiological Effect | Increased Coagulation Factor Activity |
US Patents and Regulatory Information for CALCIUM GLUCONATE IN SODIUM CHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hq Spclt Pharma | CALCIUM GLUCONATE IN SODIUM CHLORIDE | calcium gluconate | SOLUTION;INTRAVENOUS | 210906-001 | Oct 29, 2018 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Hq Spclt Pharma | CALCIUM GLUCONATE IN SODIUM CHLORIDE | calcium gluconate | SOLUTION;INTRAVENOUS | 210906-002 | Oct 29, 2018 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Hq Spclt Pharma | CALCIUM GLUCONATE IN SODIUM CHLORIDE | calcium gluconate | SOLUTION;INTRAVENOUS | 210906-001 | Oct 29, 2018 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Hq Spclt Pharma | CALCIUM GLUCONATE IN SODIUM CHLORIDE | calcium gluconate | SOLUTION;INTRAVENOUS | 210906-002 | Oct 29, 2018 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
